National Healthcare Agreement: PI 68-Proportion of health expenditure spent on health research and development, 2011

Collection and usage attributes

Health research and development expenditure comprises health research expenditure, excluding that funded by private business, undertaken at tertiary institutions, in private non-profit organisations and in government facilities that has a health socioeconomic objective (Health socio-economic objective defined by Division 92 in the Socio-economic classification of the 2008 ABS and Statistics New Zealand Australian and New Zealand Standard Research Classification (ABS and Statistics New Zealand (2008) Cat no. 1297.0).

Excludes commercially oriented research carried out or funded by private business, the costs of which are assumed to be included in the prices charged for the goods and services (e.g. medications that have been developed and/or supported by research activities).

Presented as numerator, denominator and percentage.

2007–08 and 2008–09—State and territory (numerator/denominator/percentage)

The AIHW estimates of research expenditure are derived from unpublished ABS data collected in the ABS Surveys of research and experimental development (8111.0 Research and Experimental Development, Higher Education Organisations, 2006–07 and 2008–09; and 8109.0 Research and Experimental Development, Government and Private Non-Profit, Australia, 2006–07 and 2008–09). These data are available every two years. For in-between years, AIHW makes estimates based on interpolation.

Most recent data available for 2011 CRC report: 2007–08 (updated as necessary for revised total health expenditure estimates) and 2008–09.

Representational attributes

Indicator conceptual framework

Data source attributes

Accountability attributes

Source and reference attributes

Relational attributes